Articles
Innovation and crowdsourcing in clinical trials: Interview with Dr Tomasz Sablinski

Innovation and crowdsourcing in clinical trials: Interview w...

Angela Dunn interviews Dr Tomasz Sablinski of Transparency Life Sciences, the world’s first drug development company based on Open Innovation (OI). According to the "2012 State of Global Open Innovation", Forrester defines Open Innovation (OI) as...

Articles
Top ten innovators in pharma: Rob Müller

Top ten innovators in pharma: Rob Müller

Rob Müller is our latest pharma innovator, nominated by his peers for his trailblazing efforts in social media. We asked you to nominate those who you considered to be a top innovator in pharma. We were delighted with your responses...

Articles
Tunnah’s musings: Pharma, lend me your ears and we’ll give you ours

Tunnah’s musings: Pharma, lend me your ears and we’ll give y...

As he steps back into the ‘musings’ saddle, Paul Tunnah is back from vacation refreshed and ready to go, with some exciting news about a new feature on pharmaphorum. You probably noticed that, last month, this regular ‘musings’ column was written by Rebecca Aris rather than me. That’s because I took a short holiday…

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. ESMO26: Tango sees 82% ORR with combo in pancreatic cancer
  2. Roche offers $15bn for strategic-level deal with Hansoh
  3. ESMO26: Moderna, MSD reveal cancer jab data early after leak
  4. Clinical trial setup times fall sharply in UK
  5. Despite US policy changes, drug prices stay stubbornly high

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more